Lumida
/DHR
⌘K
Danaher Corp

Danaher Corp

DHR
$200.14USD-0.19%-0.39 today

MARKET CAP

140.7B

P/E (TTM)

38.7x

FWD P/E

DAY RANGE

$199 – $203

52W RANGE

$161
$243

AI Summary

Stalk
TrimMedium

The active Bearish Pivot Point and convergence breakdown of the 9/20 EMAs under the 50-day SMA signal a medium-term repair phase. Price is nearing the 200-day SMA support zone at 200–202.5, and a clearer bounce is needed before considering bullish entries. Until then, bearish execution should be deferred and implemented on rallies into the 9/20 EMA region around 207–208, where rejection at resistance would confirm further downside. A decisive break and close below the 200-day SMA would invalidate current support and accelerate the decline.

  • New CEO Julie Sawyer Montgomery to bolster Diagnostics growth.
  • Barclays “Buy” rating signals ~9% undervaluation.
  • Growth concerns may curb future revenue expansion.
Full analysis →
STATEMENT·Income statement
USD · GAAP
METRICFY 2021FY 2022FY 2023FY 2024FY 2025TREND
Sales, Adj.$24.8B$26.6B$23.9B$23.9B$24.6B
YoY %+11.3%+7.4%-10.3%-0.1%+2.9%
P / Sales9.8x7.3x7.3x7.1x6.7x
EV / Sales11.2x8.3x8.4x8.2x7.7x
Gross Profit, Adj.$15.2B$16.2B$14.0B$14.2B$14.5B
YoY %+22.2%+6.2%-13.3%+1.2%+2.2%
Margin %61.4%60.8%58.7%59.5%59.1%
EV / Gross Profit18.2x13.7x14.2x13.7x13.1x
EBITDA, Adj.$8.4B$9.7B$7.4B$7.2B$7.1B
YoY %+40.5%+14.6%-23.7%-1.8%-1.4%
Margin %34.0%36.3%30.9%30.3%29.0%
EV / EBITDA32.9x22.9x27.1x27.0x26.7x
EBIT$6.4B$7.5B$5.2B$4.9B$4.7B
YoY %+50.7%+18.2%-31.0%-6.5%-3.6%
Margin %25.7%28.3%21.8%20.4%19.1%
EV / EBIT43.6x29.4x38.4x40.1x40.6x
Net Income$6.3B$7.1B$4.7B$3.9B$3.6B
YoY %+78.6%+13.3%-33.2%-17.8%-7.3%
Net Margin25.3%26.7%19.9%16.3%14.7%
EPS (GAAP)$8.61$9.66$6.38$5.29$5.05
YoY %+76.1%+12.2%-34.0%-17.1%-4.5%